johnson & johnson

J&J vaccine review will cause hesitancy; Blinken warns China on Taiwan

J&J vaccine review will cause hesitancy; Blinken warns China on Taiwan

Ian Bremmer shares his perspective on global politics this week on World In 60: J&J vaccine woes, Blinken warns China, Fukushima water and a large rabbit.

The race to vaccinate: Dr. Atul Gawande provides perspective

GZERO World with Ian Bremmer

The race to vaccinate: Dr. Atul Gawande provides perspective

Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins Ian Bremmer on GZERO World to discuss the latest in the global effort to vaccinate our way out of this pandemic.

Podcast: The Race to Vaccinate: Dr. Atul Gawande Provides Perspective

GZERO World with Ian Bremmer Podcast

Podcast: The Race to Vaccinate: Dr. Atul Gawande Provides Perspective

Listen: Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins the podcast to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson & Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.

Should you get the J&J vaccine? Why Dr. Atul Gawande says yes

GZERO World Clips

Should you get the J&J vaccine? Why Dr. Atul Gawande says yes

On Thursday, February 4, Johnson & Johnson requested emergency FDA approval for its single-shot vaccine. In the days since the company first released efficacy and safety data, many of the headlines focused on its lower efficacy rate compared to that of mRNA vaccines from Pfizer and Moderna. But that's the wrong takeaway, says surgeon, public health expert and former member of Biden-Harris Transition COVID-19 Advisory Board, Dr. Atul Gawande. "This is a highly effective vaccine. It stops people from getting sick. If some people have some sniffles and mild effects from the coronavirus, that's okay, this is going to stop the deadly disease. And that is the ultimate goal of the vaccine." Gawande's conversation with Ian Bremmer is part of the latest episode of GZERO World, which starts airing on public television nationwide beginning this Friday, February 5th. Check local listings.